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ise on vascular function.Dynamic exercise performed with large muscle groups
requires complex integrative cardiovascular responses
that leads to systemic increase in shear stress.1 This
exercise-mediated increase in shear stress stimulates ni-
tric oxide (NO) production in the whole circulatory sys-
tem,2-4 which takes several minutes or hours to return to
pre-exercise baseline values.2-5 Thus, after a single bout
of exercise the vascular reactivity is augmented, which
is largely dependent on NO2-5 and has been associated
with favorable after-effects of exercise on the cardiovas-
cular system,6 such as inhibited blood pressure response
during sympathoexcitatory maneuvers.6-8
The enzyme that catalyzes NO production in response
to shear stress over the endothelium is the endothelial
nitric oxide synthase (eNOS).9 The gene that codes
this enzyme is located at chromosome 7 (location
7q36) and contains 21 kb. Since the characterization
of the eNOS gene in the mid-1990s,10 many allelic var-
iations were identified. Nevertheless, only some of these
have been consistently associated with functional im-pairments11-14 and clinical end points.15 Among these
variations are a single nucleotide polymorphism (SNP)
in the promoter region (2786T.C, rs2070744), a vari-
able number of tandem repeats polymorphism in the in-
tron 4 (4b4a), and an SNP in the exon 7 (894G.T,
rs1799983). The 2786T.C polymorphism has been
shown to reduce promoter activity of the eNOS gene,
which reduces efficiency of eNOS transcription.16 The
4b4a polymorphism impairs the eNOS mRNA splicing
process, which can also reduce efficiency of eNOS tran-
scription.17 Finally, the 894G.T polymorphism alters
the structure of the eNOS enzyme and has been associ-
ated with altered eNOS localization at endothelial cav-
eolae,18 leading to reduced response to shear stress
and impaired coordination of the enzyme regulatory cy-
cle.18 Therefore, it is conceivable that these polymor-
phisms in the eNOS gene could blunt the enhancement
of vascular reactivity that is usually observed after a sin-
gle bout of exercise.
Our group recently showed that healthy subjects, who
carried the 894G.T polymorphism, had blunted vascu-
lar reactivity to ischemia12 and mental stress13 after
a single bout of exercise in comparison with wild coun-
terparts (ie, subjects without the polymorphism). Never-
theless, the impact of other eNOS gene polymorphisms
on the vascular reactivity after exercise is still unknown.
Most important, the impact of the interaction among
eNOS gene polymorphisms on the vascular reactivity
after exercise is not known, which is a relevant issue, be-
cause the influence of genetic variations on physiologic
traits can be more informative when SNPs are analyzed
concomitantly as haplotypes (combinations of genetic
markers within a chromosome cluster location).19,20
On the basis of this background, the aim of the present
study was to investigate the effect of 3 polymorphisms
in the eNOS gene (2786T.C, intron 4b4a, and
894G.T), analyzed individually as genotypes and con-
comitantly as haplotypes, on the vascular reactivity to
an ischemic stimulus performed before and after a single
bout of exercise.MATERIALS AND METHODS
Sample. Subjects were recruited through advertise-
ments at the university and in local newspapers.
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but only 105 women and 26 men met the inclusion cri-
teria and completed the study. Most of these subjects
participated in previous studies from our group.12,13
The eligibility requirements were verified through clin-
ical history assessment, physical examination, blood
pressure measurement on 2 different days, biochemical
blood analyses, resting electrocardiogram, and maxi-
mal cardiopulmonary exercise testing. Subjects had to
fulfill the following criteria to be included in the
study: age 18 to 49 years, womenwith regular menstrual
cycles, absence of any diagnosed disease and no
recent infections, body mass index (BMI) between
18.5 and 29.9 kg/m, total cholesterol , 240 mg/dL,
low-density lipoprotein (LDL) , 160 mg/dL,
triglycerides , 200 mg/dL, glycemia , 126 mg/dL,
systolic blood pressure (SBP) , 140 mm Hg or
diastolic blood pressure (DBP) , 90 mm Hg, not
smoking, not using medications with exception of
oral contraceptives, normal resting and exercise
electrocardiogram, and sedentary (not engaged in
exercise activities lasting $ 30 minutes, 3 times per
week during the last 3 months). This study protocol
was approved by the Antonio’s Pedro University
Hospital Review Board, located at the Fluminense
Federal University, and conformed to the standards set
by the latest revision of the Declaration of Helsinki.
All subjects gave written informed consent before
participation in the study.
Determination of genotypes and haplotypes. Genomic
DNA was extracted from circulating leucocytes. The
4b4a genotypewas identified directly after a polymerase
chain reaction (PCR) amplification protocol,10 and
the 2786T.C and 894G.T genotypes were
identified by PCR, followed by restriction fragment
length polymorphism. Quality control for these assays
was assessed by randomly selecting samples to be
re-genotyped by 2 independent researchers. No
misgenotyping was observed. Haplotypes for each
subject were inferred using the software PHASE
version 2.1 (University of Washington, Seatle, Wash).21
The volunteers and researchers were blinded to the
genotypes and haplotypes during the study.
2786T.C polymorphism. The PCR was performed us-
ing the following primers: sense 5’-AGG CCC TAT
GGT AGT GCC TTT-3’ and antisense 5’-TCT CTT
AGT GCT GTG GTC AC-3’. DNA was amplified for
35 cycles consisted of denaturing at 94C for 30 sec-
onds, annealing at 51C for 40 seconds, and extension
at 72C for 40 seconds. The PCR products were di-
gested by incubation with a restriction endonuclease,
NgoMIV (New England Biolabs, Ipswich, MA), at
37C for 16 hours and visualized by gel electrophoresis.4b4a polymorphism. The PCR was performed using
the following primers: sense 5’-AGG CCC TAT
GGTAGT GCC TTT-30 and antisense 50-TCT CTT
TAG TGC TGT GGT CAC-30. DNA was amplified for
35 cycles, and each cycle was composed of denaturing
at 94C for 1 minute, annealing at 49C for 40 seconds,
and extension at 72C for 40 seconds. The PCR prod-
ucts were visualized by gel electrophoresis.
894G.T polymorphism. The PCR was performed us-
ing the following primers: sense 5’ AAG GCA GGA
GAC AGT GGA TGG A-3’ and antisense 5’ CCC
AGTCAATCCCTT TGGTGCTCA-3’. DNAwas am-
plified for 35 cycles consisted of denaturing at 94C for
1 minute, annealing at 58C for 1 minute, and extension
at 72C for 1 minute. The PCR products were digested
by incubation with Ban II (New England Biolabs,
Ipswich, Mass) at 37C for 16 hours and visualized by
gel electrophoresis.
Biochemical blood analyses. Blood was drawn in the
morning after 12 hours of fasting. Cholesterol and its
subfractions (high-density lipoprotein [HDL] and
LDL], as well as triglycerides, were determined by the
dry chemistry method. Plasma glucose was measured
by enzymatic in vitro test.
Experimental protocol. The experimental protocol was
conducted in the morning, 1 hour after a standardized
light breakfast. The evaluation was performed from the
first to the 12th day after the onset of menstruation. Sub-
jects did not drink alcohol or caffeinated beverages and
did not perform intense physical activities for at least 24
hours before the experimental visit.During the study, sub-
jects were placed in a supine position in a quiet air-
conditioned room (z24C), and they rested quietly for
10 minutes before any measurement. Then, blood
pressure and vascular reactivity were assessed before
(baseline) and 10, 60, and 120 minutes after a single
bout of exercise. A subgroup of 8 subjects of the sample
also participated in a time-control protocol, which was
conducted on a different day of the experimental
protocol. The order of the control and experimental
protocols was randomized in this subgroup. The control
protocol was composed of blood pressure and vascular
reactivity assessment before (baseline) and 10, 60, and
120 minutes after standing on a treadmill for 30 minutes
without exercising, which was the approximate duration
of the whole exercise bout procedure described next.
Exercisebout. Theexercise bout consisted of a standard
maximal cardiopulmonary exercise test performed on
a treadmill (Master ATL, Inbrasport, Porto Alegre, RS,
Brazil). This consisted of 3 minutes of rest standing on
the treadmill, 3 minutes of warm-up at 3 km/h and 0%
grade, ramp protocol with linear increase in speed and
grade every minute until maximal voluntary exhaustion,
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ramp protocol was individualized according to
predicted maximal exercise capacity to reach volitional
fatigue at approximately 10 minutes of protocol.22
Subjects were verbally encouraged to exercise until
exhaustion. All subjects met at least 2 of the following
criteria to confirm that maximal effort was attained:23
(1) respiratory exchange ratio . 1.1; (2) heart rate
within 6 10 beats/min21 of the age-predicted
maximum (210 – [age/0.65]); and (3) score 10 of
perceived effort on Borg 0 to 10 scale. Ventilation,
oxygen uptake, and carbon dioxide output were
measured with each breath (CPX Ultima Gas Exchange
System, Medgraphics Corp, St Paul, Minn).
Electrocardiogram was monitored through 12 leads
(Welch Allyn CardioPerfect Workstation, Welch Allyn,
Skaneateles Falls, NY), and perceived exertion was
assessed every minute. Breath-by-breath ventilation and
expired gases were averaged to 20 seconds to identify
peak oxygen consumption (VO2peak), which was
considered the highest value of oxygen uptake during
exercise.
Vascular reactivity. Vascular reactivity was assessed
through venous occlusion plethysmography. The right
arm was supported in a comfortable position, elevated
above the level of the heart at a standardized height.
Two cuffs were used; one (8 cmwide) was placed around
the right wrist, and one (10 cm wide) was placed around
the right upper arm. The arm cuff was attached to a rapid
cuff inflator (EC6, Hokanson, Bellevue, Wash). A mer-
cury in silastic strain gauge (Hokanson, Bellevue,
Wash) was placed at the widest girth of the right forearm.
The diameter of the strain gauge was 1 or 2 cm smaller
than the widest girth of the forearm. Forearm blood
flow (FBF) was measured during 3 minutes at pre- and
postischemia by means of rapidly inflating the arm cuff
(,0.5 seconds) to 50 mm Hg, maintaining this pressure
for 10 seconds, and rapidly deflating it to 0mmHg,main-
taining this pressure for 10 seconds, thus completing a 20-
second cycle.During theFBFmeasurement, thewrist cuff
was inflated to 220mmHg to exclude the influence of the
hand circulation.24 Ischemia was evoked by inflation of
the arm cuff to 200 mm Hg during 5 minutes. Blood
pressure was measured on the left arm by the
auscultatory method, using a calibrated mercury
sphygmomanometer with an appropriate cuff size, once
at the beginning of preischemia FBF measurement and
once at the beginning of postischemia FBFmeasurement.
FBF was calculated by a semiautomatic method,
which has shown high intra- and interevaluator repro-
ducibility (intraclass correlation coefficients between
0.98 and 0.99).25 Mean blood pressure (MBP) was
used to calculate forearm vascular conductance (FVC;FBF/MBP). Thereafter, the area under the FVC curve
was calculated pre- and postischemia. The percent in-
crease in area under the FVC during postischemia,
above the correspondent area under the FVC during pre-
ischemia, was considered as the study’s vascular reac-
tivity measure and used as the main end point for
statistical analyses.
Statistical analyses. The sample size was estimated on
the basis of pilot data and results from previous stud-
ies.12,13 For a 2-way analysis of variance (ANOVA) (2
groups and 4 repeated measures), a total sample size of
120 subjects would be necessary to detect a difference
of 35% between groups’ vascular reactivity (group main
effect), considering a standard deviation within groups
of 90%, P value of 0.05, and power of 0.80. Shapiro–
Wilk’s test was used to verify variables’ distribution,
Levene’s test was used to verify homoscedasticity, and
Mauchly’s test was used to verify sphericity. Some
variables were not normally distributed (ie, age, BMI,
triglycerides, HDL, glycemia, VO2peak, SBP, and
vascular reactivity), and thus were transformed into
natural logarithms for inferential analyses. After
logarithm transformation, there was no violation of
the homoscedasticity assumption in any analyses.
Nonetheless, vascular reactivity results deviated from
the sphericity assumption, which required a correction
that is described next.
Three genetic models (dominant, recessive, and addi-
tive) were assessed to verify which model was better to
fit the vascular reactivity data on partial correlations
adjusted by all sample characteristics. In these partial
correlations, eNOS gene polymorphisms were analyzed
as dummy variables as follows: dominant model (het-
erozygous 1 polymorphic homozygous 5 0 vs wild
homozygous5 1), recessive model (polymorphic homo-
zygous 5 0 vs wild homozygous 1 heterozygous 5 1),
and additive model (polymorphic homozygous 5 0 vs
heterozygous5 1 vs wild homozygous5 2). Then, sub-
jects’ characteristics according to genotypes and haplo-
types were compared using independent Student t test
or chi-square test. Specifically in the analyses of haplo-
types, characteristics of the wild haplotype (haplotype
1 [H1]) were separately compared with each of the poly-
morphic haplotypes (ie, H1 vs haplotype 2 [H2], H1 vs
haplotype 3 [H3], H1 vs haplotype 4 [H4]) according to
the method of planned comparisons against a control
group.26
The effect of exercise or time-control (ie, no exer-
cise) protocols on vascular reactivity was analyzed
by means of a repeated-measures ANOVA, followed
by the Fisher post hoc test in case of significant F
values. Vascular reactivity was compared between
groups using analysis of covariance (ANCOVA)
Table I. Partial correlations among eNOS gene
polymorphisms and vascular reactivity before
(baseline) and 10, 60 and 120 minutes after exercise
according to dominant, recessive, and additive
genotype models
Dominant model
Locus 2786 Intron 4 Locus 894
r P r P r P
Baseline 0.06 0.52 0.04 0.69 0.09 0.36
10 min 0.08 0.42 0.11 0.22 20.01 0.90
60 min 0.09 0.34 0.11 0.22 0.16 0.09
120 min 0.19 0.04 0.05 0.61 0.24 0.01
Recessive model
Locus 2786 Intron 4 Locus 894
r P r P r P
Baseline 0.08 0.40 0.05 0.63 0.06 0.53
10 min 20.01 0.98 20.05 0.59 0.03 0.79
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sidered as covariates. At first, a model was used to
compare the baseline vascular reactivity between
groups. Then, a different model was used to compare
groups throughout time (ie, ANCOVA main factors:
group [wild vs polymorphic] and time [baseline vs
10 minutes vs 60 minutes vs 120 minutes]). In the
ANCOVA of the haplotypes, the haplotype containing
only wild-type alleles (H1) was separately compared
with each of the haplotypes containing polymorphic
alleles (ie, H1 vs H2, H1 vs H3, H1 vs H4).26 Green-
house–Geisser correction was used to correct P values
from ANCOVA main effects due to deviation from the
sphericity assumption. In case of significant F values,
Cohen’s d effect size was calculated. Results are pre-
sented as mean 6 standard error of the mean. Statisti-
cal significance was considered for P # .05 based on
2-tailed comparisons. All analyses were performed
using STATISTICA version 8.0 software (StatSoft
Inc, Tulsa, Okla).60 min 20.04 0.70 20.10 0.26 20.04 0.69
120 min 0.10 0.30 20.07 0.47 0.08 0.39
Additive model
Locus 2786 Intron 4 Locus 894
r P r P r P
Baseline 0.16 0.08 0.08 0.39 0.13 0.17
10 min 0.04 0.64 0.04 0.70 0.01 0.96
60 min 20.04 0.71 20.15 0.11 20.09 0.34
120 min 0.05 0.62 20.10 0.27 0.05 0.63
Dominant model (heterozygous 1 polymorphic homozygous vs
wild homozygous), recessive model (polymorphic homozygous
vs wild homozygous 1 heterozygous), and additive model
(polymorphic homozygous vs heterozygous vs wild homozy-
gous). n 5 131. P values in bold font are statistically significant
(ie, P # 0.05).RESULTS
The characteristics of the entire sample were as
follows: age 32 6 1 years, BMI 25.0 6 0.3 m/kg, total
cholesterol 176 6 3 mg/dL, HDL 55 6 1 mg/dL, LDL
104 6 2 mg/dL, triglycerides 89 6 3 mg/dL, glycemia
85 6 1 mg/dL, VO2peak 31.1 6 0.7 mL/kg/min, SBP
1146 1 mm Hg, and DBP 736 1 mm Hg. Vascular re-
activity increased 10 minutes after exercise in the entire
sample (main effect P , 0.01; baseline: 218 6 11% vs
10 minutes: 284 6 15%, P 5 0.001), remained in-
creased at 60 minutes (239 6 12%, P 5 0.02 vs base-
line), and returned to baseline at 120 minutes (210 6
10%, P 5 0.83 vs baseline). In the control protocol,
there was no change in vascular reactivity (main effect
P 5 0.96; baseline 5 227 6 24%, 10 minutes 5 228
6 36%, 60 minutes 5 237 6 31%, 120 minutes 5
237 6 29%).
The distribution of genotype frequencies for the poly-
morphisms studied showed no deviation from Hardy–
Weinberg’s equilibrium (locus 2786, P 5 0.93; intron
4, P 5 1.00; locus 894, P 5 0.70). Two subjects had
the 4b4c genotype, and 1 subject had the 4c4c genotype.
Because of the low frequency of the c allele, subjects
with the 4b4c genotype were grouped with those with
the 4b4a genotype, whereas the subject with the 4c4c
genotype was grouped with those with the 4a4a geno-
type. Table I shows partial correlations among eNOS
gene polymorphisms and vascular reactivity according
to dominant, recessive, and additive models. There
were significant associations among the genotypes at lo-
cus 2786 and locus 894 with the vascular reactivity at
120 minutes after exercise only in the dominant model,where the presence of the wild genotype was associated
with higher vascular reactivity (ie, positive correlation
coefficient). Therefore, only the dominant model was
used in further genotype analyses.
There was no difference among the characteristics of
the groups in genotypes analyses (Table II), with the ex-
ception of higher SBP and DBP in subjects with the
polymorphic genotype at intron 4 compared with wild
counterparts (P5 0.01). Moreover, there was no differ-
ence between genotype groups regarding the day that
women were evaluated in the follicular phase of the
menstrual cycle (locus 2786, P 5 0.53; intron 4, P 5
0.07; locus 894, P 5 0.50) or in the amount of women
taking oral contraceptives (locus 2786, P 5 0.87; in-
tron 4, P 5 0.14; locus 2894, P 5 0.31). The vascular
reactivity was compared between genotype groups, first
considering only the baseline vascular reactivity. In
Table II. Subjects’ characteristics according to
a dominant model of eNOS genotypes
Genotypes at locus 2786
Wild
(n 5 60)
Polymorphic
(n 5 71) P
Gender (F/M) 52/8 53/18 0.13
Age (y) 32 6 1 31 6 1 0.77
BMI (kg/m) 25.3 6 0.4 24.9 6 0.3 0.50
Cholesterol (mg/dL) 178 6 4 174 6 4 0.45
HDL (mg/dL) 54 6 2 56 6 2 0.74
LDL (mg/dL) 106 6 3 102 6 4 0.50
TG (mg/dL) 93 6 5 86 6 4 0.41
Glucose (mg/dL) 85 6 1 85 6 1 0.92
SBP (mm Hg) 114 6 1 114 6 1 0.91
DBP (mm Hg) 74 6 1 72 6 1 0.27
VO2peak (mL/kg/min) 30.3 6 0.9 31.7 6 0.9 0.31
Genotypes at intron 4
Wild
(n 5 95)
Polymorphic
(n 5 36) P
Gender (F/M) 76/19 29/7 0.86
Age (y) 32 6 1 31 6 1 0.94
BMI (kg/m) 24.8 6 0.3 25.7 6 0.5 0.13
Cholesterol (mg/dL) 177 6 3 173 6 6 0.44
HDL (mg/dL) 54 6 1 57 6 2 0.37
LDL (mg/dL) 105 6 3 100 6 5 0.38
TG (mg/dL) 90 6 4 86 6 5 0.77
Glucose (mg/dL) 85 6 1 85 6 2 0.86
SBP (mm Hg) 112 6 1 117 6 2 0.01
DBP (mm Hg) 72 6 1 76 6 1 0.01
VO2peak (mL/kg/min) 30.9 6 0.8 31.6 6 1.3 0.68
Genotypes at locus 894
Wild
(n 5 64)
Polymorphic
(n 5 67) P
Gender (F/M) 52/12 53/14 0.93
Age (y) 32 6 1 32 6 1 0.94
BMI (kg/m) 24.9 6 0.4 25.2 6 0.3 0.46
Cholesterol (mg/dL) 176 6 4 176 6 4 0.89
HDL (mg/dL) 54 6 2 56 6 2 0.55
LDL (mg/dL) 103 6 3 104 6 4 0.89
TG (mg/dL) 91 6 5 88 6 5 0.68
Glucose (mg/dL) 85 6 1 85 6 1 0.83
SBP (mm Hg) 115 6 1 113 6 1 0.18
DBP (mm Hg) 74 6 1 71 6 1 0.08
VO2peak (mL/kg/min) 31.9 6 1.0 30.3 6 0.8 0.25
Abbreviations: BMI, bodymass index;HDL, high-density lipoprotein;
LDL, low-density lipoprotein; TG, triglycerides; SBP, systolic blood
pressure;DBP, diastolic blood pressure; VO2peak, peak oxygen con-
sumption.
Data are mean6 standard error of the mean. Genotypes at locus
2786: wild 5 TT, polymorphic 5 TC or CC; genotypes at intron 4:
wild 5 4b4b, polymorphic 5 4b4a, 4a4a, 4bc or 4c4c; genotypes
at locus 894: wild 5 GG, polymorphic 5 GT or TT. P values in bold
font are statistically significant (ie, P # 0.05).
Fig 1. Vascular reactivity before and 10, 60, and 120 minutes after ex-
ercise according to a dominant model of eNOS genotypes. Genotypes at
locus2786: wild5 TT (n5 60), polymorphic5 TC or CC (n5 71);
genotypes at intron 4: wild 5 4b4b (n 5 95), polymorphic 5 4b4a,
4a4a, 4bc or 4c4c (n 5 36); genotypes at locus 894: wild 5 GG
(n 5 64), polymorphic 5 GT or TT (n 5 67). BL, baseline.
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cular reactivity between groups (locus2786, P5 0.52;
intron 4, P5 0.69; locus 894, P5 0.36). Figure 1 showsthe comparison of groups, according to genotypes,
throughout time. There was a group main effect for
the genotype at locus 894 (P 5 0.05), where subjects
with the polymorphic genotype had lower vascular reac-
tivity than wild counterparts. This yielded an effect size
of 0.29 (95% confidence interval, 0.21–0.37).
Estimated haplotype frequencies for our sample are
presented in Table III. H1, which had only wild alleles,
was the most common haplotype. Haplotypes 5 (H5), 6
(H6), and 7 (H7) were relatively uncommon (frequency
, 5%) and were not considered for further analyses,
which is a standard approach in eNOS haplotype
Table III. Estimated haplotype frequencies
Haplotypes
Alleles
n
Frequency
(%)Locus 2786 Intron 4 Locus 894
H1 T 4b G 143 54.6
H2 C 4b T 51 19.5
H3 C 4a G 28 10.7
H4 T 4b T 25 9.5
H5 T 4a G 8 3.1
H6 C 4b G 4 1.5
H7 T 4c G 3 1.1
Total 100.0
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tics showed that H1 had lower SBP than H3, lower
BMI than H4, and higher VO2peak than H4 (Table IV).
There was no difference between haplotype groups re-
garding the day that women were evaluated in the follic-
ular phase of the menstrual cycle (H1 vs H2, P 5 0.43;
H1 vs H3, P 5 0.87; H1 vs H4, P 5 0.81) or in the
amount of women taking oral contraceptives (H1 vs
H2, P5 0.70; H1 vs H3, P5 0.15; H1 vs H4, P5 0.20).
The vascular reactivity was compared between haplo-
type groups, first considering only the baseline vascular
reactivity. In these analyses, there was no difference in
baseline vascular reactivity between groups (H1 vs
H2, P 5 0.43; H1 vs H3, P 5 0.87; H1 vs H4, P 5
0.81). Figure 2 shows the comparison of groups, accord-
ing to haplotypes, throughout time. There was a group
main effect in the comparison between H1, which con-
tained only wild alleles, and H2, which contained poly-
morphic alleles at locus2786 and 894 (P5 0.05). This
yielded an effect size of 0.27 (95% confidence interval,
0.22–0.36). There was no difference in the vascular re-
activity between H1 and H3, and between H1 and H4.
DISCUSSION
The present study investigated the impact of 3 poly-
morphisms in the eNOS gene on healthy subjects’ vas-
cular reactivity to ischemia, which was evaluated
before and after a single bout of exercise. The main re-
sults were as follows: 1) The dominant genotype model
had the best correlations with vascular reactivity, in
which the polymorphic genotypes at locus 2786 and
894 were statistically associated with lower vascular re-
activity at 120 minutes after exercise independently of
other phenotypic characteristics; 2) subjects with poly-
morphic genotype at locus 894 had lower vascular reac-
tivity than wild counterparts; 3) subjects with H2, which
contained polymorphic alleles at locus 2786 and 894,
had lower vascular reactivity than wild counterparts
(H1), whereas subjects with H4, which contained only
the polymorphic allele at locus 894, had vascular reac-tivity similar to wild counterparts (H1). Altogether,
these results indicate that the 894G.T polymorphism
reduced the exercise-mediated increase in vascular reac-
tivity, particularly when it occurred concomitantly with
the 2786T.C polymorphism.
The vasodilation that occurs after a temporary vascular
occlusion is known to be attributed to 3 major mecha-
nisms: (1) Mechanical myogenic vasodilatation is caused
by a decrease in intravascular pressure distal to the occlu-
sion,which is an endothelium-independentmechanism;27
(2)metabolic vasodilatationmediated by substances such
as prostaglandins, adenosine diphosphate, and potassium,
which are generated by the ischemic tissues, yields vaso-
dilatation through endothelium-independent and depen-
dent mechanisms;27-29 and (3) the prompt release of the
circulation, summed by the myogenic and metabolic
vasodilatation, provokes a large increase in shear stress,
which stimulates the endothelium-dependent production
of NO.28-30
Although multiple mechanisms are responsible for
the vascular reactivity to ischemia, previous studies
that used venous occlusion plethysmography to evalu-
ate the vascular reactivity have shown that NO accounts
for approximately 25% of this phenomenon.28-30 Fur-
thermore, when the vascular reactivity to pharmaco-
logic infusions was evaluated after a bout of exercise,
the vasodilator response relied 50% on the NO path-
way,31 indicating that the contribution of NO to the vas-
cular reactivity is enhanced after exercise. It is
noteworthy that the vascular reactivity increases after
exercise even in vascular beds not directly involved
with the muscular contractions.5 This was also ob-
served in the present study, in which exercise was per-
formed with the lower limbs and vascular reactivity
increased in the forearm. Such effect was independent
of time or repeated exposure to ischemia, because the
vascular reactivity did not change in the control non-
exercise protocol. The effect was also independent of
blood pressure, because we took into account its contri-
bution through the analysis of vascular conductance (ie,
FBF divided by MBP).
In the present study, the polymorphisms 2786T.C,
intron 4b4a, and 894G.T in the eNOS gene did not in-
fluence baseline (ie, before exercise) vascular reactivity
to ischemia. Other studies that also evaluated the impact
of eNOS gene polymorphisms on the baseline vascular
reactivity to ischemia have shown similar results. For
example, Rasool et al32 investigated the influence of
the 894G.T polymorphism on skin microvascular reac-
tivity to an ischemic stimulus and found no significant
difference between subjects with wild and polymorphic
genotypes. Kathiresan et al33 investigated the influence
of various SNPs, isolated or as haplotypes, on brachial ar-
tery flow–mediated dilation and hyperemic flowvelocity.
Table IV. Subjects’ characteristics according to eNOS haplotypes
H1 (n 5 143) H2 (n 5 51) H3 (n 5 28) H4 (n 5 25)
H1 vs H2 H1 vs H3 H1 vs H4
P P P
Gender (F/M) 116/27 38/13 21/7 22/3 0.32 0.46 0.41
Age (y) 31 6 1 31 6 1 31 6 2 33 6 2 0.98 0.98 0.33
BMI (kg/m22) 24.8 6 0.3 24.4 6 0.4 25.5 6 0.6 26.5 6 0.5 0.53 0.33 0.01
Cholesterol (mg/dL21) 177 6 3 176 6 5 172 6 7 180 6 7 0.79 0.40 0.73
HDL (mg/dL21) 54 6 1 54 6 2 58 6 3 58 6 3 0.84 0.26 0.23
LDL (mg/dL21) 105 6 2 105 6 4 98 6 6 105 6 5 0.97 0.23 0.94
TG (mg/dL21) 91 6 3 85 6 5 88 6 6 96 6 8 0.48 0.97 0.50
Glucose (mg/dL21) 85 6 1 84 6 1 86 6 2 86 6 2 0.59 0.82 0.84
SBP (mm Hg) 113 6 1 111 6 1 118 6 2 114 6 2 0.19 0.02 0.81
DBP (mm Hg) 72 6 1 70 6 1 75 6 2 73 6 2 0.13 0.11 0.76
VO2peak (mL/kg
21/min21) 31.2 6 0.6 32.2 6 1.1 34.0 6 3.0 30.3 6 3.3 0.41 0.93 0.02
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides; SBP, systolic blood pressure;
DBP, diastolic blood pressure; VO2peak, peak oxygen consumption.
Data are mean 6 standard error of the mean. H1, haplotype 1 (alleles: 2786T/4b/894G); H2, haplotype 2 (alleles: 2786C/4b/894T); H3, haplo-
type 3 (alleles: 2786C/4a/894G); H4, haplotype 4 (alleles: 2786T/4b/894T). P values in bold font are statistically significant (ie, P # 0.05).
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tween eNOS gene polymorphisms and endothelial func-
tion. In addition, Vasan et al,34 using a genome-wide
analysis, found no association among the polymor-
phisms 2786T.C, intron 4b4a, and 894G.T in the
eNOS gene and brachial artery flow–mediated dilation
or hyperemic flow velocity.
In contrast with the baseline results of the present
and previous studies,32-34 the exercise-mediated en-
hancement of vascular reactivity in subjects with the
polymorphic genotype at locus 894 was lower than
in wild counterparts. This result indicates that exercise
seems to disclose a difference in vascular reactivity
between healthy subjects with and without the
894G.T polymorphism, which is not evident before
exercise. In addition, haplotype analyses showed that
subjects with H2, which contained polymorphic al-
leles at locus 2786 and 894, had lower vascular reac-
tivity than wild counterparts (H1), whereas subjects
with H4, which contained only the polymorphic allele
at locus 894, had vascular reactivity similar to wild
counterparts (H1). Therefore, the polymorphism
894G.T led to a reduction in vascular reactivity, par-
ticularly when it occurred simultaneously with the
2786T.C polymorphism. Overall, the present results
corroborate the findings of a previous study from our
group that observed similar vascular reactivity to is-
chemia at baseline, but lower and shorter-lasting vas-
cular reactivity to ischemia in subjects with the
polymorphism 894G.T after a single bout of exer-
cise,12 and advance these findings showing the impor-
tance of eNOS haplotypes.
In the present study, haplotype containing 2 poly-
morphic alleles (H2) had lower vascular reactivitythan haplotype containing only wild alleles (H1).
Silva et al14 found that subjects with the haplotype
2786C/4b/894T had lower parasympathetic modula-
tion after exercise training, which is comparable to
the attenuated effect of exercise in subjects with the
same haplotype (H2) in the present study. It is worth
noting that despite the fact that both the study by
Silva et al and the current study were conducted in
Brazil, the samples were composed of different sub-
jects. On the other hand, Metzger et al35 found that
healthy subjects with the haplotype 2786C/4b/894G
had lower NO bioavailability, whereas Nejatizadeh
et al20 found that hypertensive subjects with the hap-
lotype 2786T/4a/894T had lower NO bioavailability.
These haplotypes were not frequent in the present
study compared with the studies above20,35, probably
because of differences in ethnicity36-38; consequently,
they were not considered for statistical analyses.
It is widely accepted that chronic adaptations induced
by exercise training are caused by the sum of successive
acute exposures to exercise.6 In this sense, Dias et al11
showed attenuated NO-mediated vasodilation during
exercise in subjects with the 894G.T polymorphism.
In addition, the present study showed impaired vascular
reactivity after an exercise bout when the 2786T.C
and 894G.T polymorphisms occurred simultaneously.
Therefore, the potential implication of these findings is
that subjects with these polymorphisms may have lower
levels of eNOS transcription (2786T.C polymor-
phisms) and activation (894G.T polymorphism) dur-
ing and after each exposure to exercise, which could
lead to a blunted effect of exercise training on the vascu-
lar function. Furthermore, it is possible that the interac-
tion between eNOS gene polymorphisms with risk
Fig 2. Vascular reactivity before and 10, 60, and 120 minutes after ex-
ercise according to eNOS haplotypes. H1, haplotype 1 (alleles:
2786T/4b/894G; n 5 143); H2, haplotype 2 (alleles: 2786C/4b/
894T; n 5 51); H3, haplotype 3 (alleles: 2786C/4a/894G; n 5 28);
H4, haplotype 4 (alleles: 2786T/4b/894T; n 5 25); BL, baseline.
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these genetic variations, increasing the risk for cardio-
vascular diseases and cardiovascular events.15,39
The present study should be interpreted in light of
some limitations. First, we sought to analyze 3 polymor-
phisms that have been shown to be relevant to determine
cardiovascular traits11,12 and to be associated with in-
creased risk for cardiovascular disease.15,40 However,
the eNOS gene has many other variations.10 Therefore,
other studies should investigate the impact of other
eNOS gene polymorphisms, and their interaction with
those investigated in the current study, on the vascular
reactivity before and after exercise. Second, our sample
size did not allow us to analyze the isolated influence of
genotypes containing only polymorphic alleles or
paired haplotypes per subject. Nevertheless, a greater
difference would be expected among genotypes and
haplotypes if these analyses were performed, making
it unlikely that our interpretation was jeopardized.
Third, the Brazilian population is racially heteroge-
neous, which makes the characterization of ethnicity al-
most impossible.41 Despite the evidence that in
Brazilians and Americans the 2786T.C and
894G.T polymorphisms are more common in whites
than in blacks, and the 4b4a polymorphism is more
common in blacks than in whites,36,37 it seems that de-
fining genetic markers is more important than ethnic
classification, at least in terms of NO bioavailability.42
In addition, it seems that in Brazil there is no difference
among ethnicities regarding cardiovascular impair-
ments related to eNOS gene polymorphisms.43 Fourth,
we did not measure NO metabolites (nitrite and nitrate)
or perform intra-arterial pharmacologic infusions to as-
sess the direct participation of NO on the vascular reac-
tivity. However, there is evidence that subjects with
eNOS gene polymorphisms have lower NO bioavail-
ability,19,31,44,45 which was probably the reason whythey had lower vascular reactivity. Furthermore, we
evaluated healthy subjects, which avoided biasing vari-
ables such as comorbidities and medications use, and in
our study important phenotypic variables (ie, gender,
age, BMI, cholesterol, HDL, LDL, triglycerides, glyce-
mia, blood pressure, and VO2peak) were used as covari-
ates in all ANOVA analyses, which reduced the
influence of confounding factors.
Finally, we used a cardiopulmonary exercise test to
investigate the effect of exercise on the vascular reactiv-
ity. Although this protocol differs from regular exercise
training sessions, it has the advantage to be a well-
established protocol to evaluate integrative cardiovascu-
lar, respiratory, and muscular function. Moreover, there
is evidence that the vascular reactivity of healthy sub-
jects is usually augmented until 60 minutes after this
type of protocol,5,12 mainly because of an increase in
the bioavailability of NO.2,3 Thus, these characteristics
provided a reasonable background to interpret the im-
pact of eNOS gene polymorphisms on the vascular reac-
tivity after exercise.CONCLUSIONS
The present results indicate that the 894G.T poly-
morphism reduced the exercise-mediated increase in
vascular reactivity, particularly when it occurred con-
comitantly with the 2786T.C polymorphism. There-
fore, these novel findings help to clarify the influence
of eNOS genetic variations on the after-effect of exer-
cise on vascular function and depict the importance of
haplotype analyses.
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